Multi-Strain Probiotic Composition for Weight Loss
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current probiotic formulations are limited in their ability to effectively regulate energy balance and promote weight loss, as they do not combine the necessary characteristics to address obesity effectively.
Innovation Solution
A probiotic composition comprising equal proportions of Lactobacillus gasseri, Lactobacillus fermentum, and Lactobacillus rhamnosus, administered in capsules or tablets with a flow agent and prebiotics to facilitate digestion and colonization, promoting weight reduction and maintenance by regulating gut flora and inflammatory responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a single probiotic strain is used, then the formulation is simple and easy to manufacture, but the effectiveness in regulating energy balance and promoting weight loss is limited
Solution Approach 1:
The patent combines three different probiotic strains (Lactobacillus gasseri, Lactobacillus fermentum, and Lactobacillus rhamnosus) into a single formulation. Each strain contributes different beneficial properties: L. gasseri for fat metabolism regulation, L. fermentum for cholesterol management, and L. rhamnosus for immune support. This combination approach resolves the contradiction by maintaining manufacturing simplicity while significantly enhancing weight loss effectiveness through synergistic effects of multiple strains working together.
Solution Approach 2:
The probiotic formulation uses a composite structure containing three distinct bacterial strains in specific proportions (each strain at 1-10 billion CFU per capsule). This composite probiotic material provides enhanced functionality compared to single-strain formulations, addressing the effectiveness limitation while preserving ease of manufacture through a standardized multi-strain capsule design.
2Productivity
If surgical options are used to treat obesity, then weight loss can be achieved, but the treatment becomes invasive and expensive with potential health complications
Solution Approach 1:
The patent replaces invasive mechanical surgical interventions with a biological therapy approach using probiotic bacteria. Instead of physically altering the digestive system through surgery, the formulation uses live microorganisms to naturally regulate metabolism, fat absorption, and energy balance. This substitution eliminates surgical invasiveness and associated complications while achieving comparable weight loss effectiveness through biological mechanisms.
Solution Approach 2:
The probiotic bacteria serve as intermediary agents that mediate between dietary intake and metabolic processing. These live microorganisms act as biological catalysts in the digestive system, influencing fat metabolism, cholesterol synthesis, and energy expenditure without requiring direct physical intervention. This intermediary approach provides a safe, non-invasive alternative to surgery while maintaining weight loss productivity.
3Object-affected harmful factors
If low energy density products are developed, then obesity risk is reduced, but the products lack satiety and nutritional completeness
Solution Approach 1:
The probiotic formulation enables the digestive system to self-regulate energy balance and metabolism through the action of beneficial bacteria. These microorganisms naturally modulate fat absorption, regulate appetite hormones, and influence energy expenditure without requiring external control of dietary composition. This self-service mechanism allows normal dietary intake while preventing obesity, avoiding the nutritional deficiencies associated with restricted low-energy-density diets.
Data Source
AI summary
A composition of probiotics is provided which promotes weight loss and maintenance thereof. More particularly, a probiotic mixture of Lactobacillus gasseri, Lactobacillus fermentum, and Lactobacillus rhamnosus are provided to reduce body adiposity, decrease inflammation of adipose tissue, and enhance metabolism in optional combination with prebiotics and excipients such as flow agents and binders. A method of administering the probiotic composition to an individual user is also provided.